In the context of malignancy, increased levels of CST7 have been correlated with a poorer prognosis in liver metastasis following colorectal cancer (12) and with improved survival in the context of pancreatic ductal adenocarcinoma (13) and hepatocellular carinoma (14). This evidence concerns the gene CST7 and pancreatic ductal adenocarcinoma.